The SAGE Handbook of Healthcare

Publisher SAGE

Format

eBook

2nd Edition 1st Edition

Quantity

Add New

Publisher

SAGE

Volume

Copyright

2008

ISBN13

9781847877000

Release

Format

eBook

Grade Level

College Freshman - College Senior

DDC
TBD
Overview

With escalating healthcare costs, changes to the regulatory control on pharmaceutical industries and the inevitable adjustments made in policies and investment in healthcare there is enormous interest in the commercial as well as the scientific aspects of today's healthcare industry.
The SAGE Handbook of Healthcare provides an authoritative analysis of the current (and anticipated) developments in the global healthcare industries. Providing a unique perspective that interfaces between the science and business aspects, it combines information on the latest scientific developments with applied, commercial business data from the global marketplace.
The Handbook focuses on the aspects of paramount importance in the healthcare sector:
Pharmacoeconomics
Pharmacogenomics
Therapeutics

Diagnostics
Areas covered include:
The role of nanotechnology, genomics and cell therapy in medicine
Diagnostics; Biomarkers and technological advances
Case studies in oncology and cardiovascular and CNS therapeutics
Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Contents.
Preface.
Foreword.
1: Pharmacoeconomics.
2: Medicare Part D: An Outlook.
3: Changes in US Oncology Drug Reimbursement: Medicare Sets the Pace.
4: Prospective Payment Systems: Opportunities and Threats for the Pharmaceutical Industry.
5: Off-label Prescribing: Overcoming the Reimbursement Barrier.
6: Pricing and Reimbursement Issues in Neurology.
7: Authorized Generics: Look Before You Leap.
8: Pharmaceutical Pricing and Reimbursement in Canada.
9: Contrasting European and US Patent Laws: Issues for the Pharmaceutical Industry.
10: The Changing Face of European Drug Registration.
11: The Impact of Reference Pricing in Europe.
12: Pharmaceutical Pricing, Reimbursement, and Prescribing in the United Kingdom.
13: Pharmaceutical Pricing, Reimbursement, and Prescribing in Italy.
14: Pharmaceutical Pricing, Reimbursement, and Prescribing in Spain.
15: The Impact of German Reference Pricing on Statins.
16: Opportunities and Challenges in the Japanese Market for Cancer Therapies.
17: Cancer Therapies Face Increasing Reimbursement Pressures in Europe and Japan.
18: The Pharmaceutical Pricing and Reimbursement Environment in China.
19: Will Point of Care Come of Age by 2010?.
20: Pharmacogenomics.
21: Has Genomics Failed to Deliver?.
22: The Role of Pharmacogenomics in Personalized Medicine.
23: Cell Therapy: A Decade of Opportunity.
24: Nanotechnology in Medicine: Its Time Has Come.
25: Clinical Proteomics: An Engine for In vitro Diagnostics Growth?.
26: Therapeutics.
27: Oncology.
28: Novel Strategies in Oncology Clinical Trials: The Use of Biological and Imaging Biomarkers.
29: Antitumor Biologies: Strategies for Success in An Expanding Market.
30: Outlook for Cancer Vaccine Development.
31: Advances Imminent in Antiangiogenesis Therapeutics.
32: Discoveries and Challenges in Early-Stage Apoptosis Drug Development.
33: Chronic Lymphocytic Leukemia: Monoclonal Antibodie
Read More Read Less

The SAGE Handbook of Healthcare

Product Details

Overview

Table of Contents